Pfizer Inc. (PFE) Share Price ($):29.10 Price Change: -0.06 (-0.21%)

Volume 29,927,760 Avg Volume 31,673,036
Day's Low $28.92 Day's High $29.20
52-wk Low $21.40 52-wk High $29.44
Previous Close $29.16 Open Price $28.96
Dividend $ 0.24 Yield 3.30%
Market Cap 209,102,000,000 P/E (Forward) 12.76
Chart for PFE
Exchange: NYSE Industry: Pharmaceuticals & Biotechnology Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes: What's This?
    Article Time Date Source
    'Guided Missiles' to Treat Cancer 10:41 AM Apr 5, 2013  WSJ.com
    Acura Pharmaceuticals Awarded U.S. Patent for Abuse Deterrent Drug Formulations 4:14 PM Apr 4, 2013  PR
    Advil(R) Launches Advil(R) Relief in Action Campaign Celebrating Active Volunteers Who Don't Let Pain Hold Them Back 8:59 AM Apr 4, 2013  PR
    Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles for Recoupment Policies Covering Major Compliance Failures 8:50 AM Apr 4, 2013  PR
    U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH 8:47 AM Apr 4, 2013 Dow Jones Global News Select
    U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH 6:39 AM Apr 4, 2013 Dow Jones Global News Select
    Drug Firms Expand Powers to Recoup Pay 7:17 PM Apr 3, 2013  WSJ.com
    Pfizer Recalls Thyroid Drug Over Odor 8:32 PM Apr 3, 2013  WSJ.com
    Pfizer Recalls Thyroid-Disorder Drug Over Odor Problem 6:04 PM Apr 3, 2013 Dow Jones Global News Select
    Options Traders Position for Health-Care Pullback 4:12 PM Apr 2, 2013  WSJ.com
    Citi Adds 11 U.S. Stocks To CDS-Screened Dividend Picks 2:52 PM Apr 2, 2013  Barrons.com
    Vitamins Attract Consumer-Products Makers 7:25 PM Mar 31, 2013  WSJ.com
    Pfizer Loses Bid to Dismiss Investors' Suit Over Celebrex -Report 9:41 PM Mar 28, 2013 Dow Jones Global News Select
    Pfizer's BOSULIF(R) (bosutinib) Receives Conditional Marketing Authorization From The European Commission 2:59 AM Mar 28, 2013  PR
    Pfizer Invites Public to View and Listen to Webcast of April 30 Conference Call with Analysts 9:59 AM Mar 26, 2013  PR
    XELJANZ(R) (tofacitinib citrate) Approved in Japan for the Treatment of Adults with Rheumatoid Arthritis (RA) 6:59 AM Mar 25, 2013  PR
    Lpath Granted Key European and U.S. Patents Related to Anti-Cancer Drug Program, ASONEP 8:31 AM Mar 22, 2013  PR
    Emerging Markets Evening Roundup: Chile's Economy Grows; Colombia Rate Cut No Sure Thing 4:16 PM Mar 18, 2013  Barrons.com
    Holding Cash Kings In A Down Market 4:06 PM Mar 18, 2013  Barrons.com
    UPLYSO(TM) (alfataliglicerase) Approved in Brazil -2- 2:14 PM Mar 18, 2013  PR
    • Print Snapshot
    • Stock Compare
    • Receive Stock Alerts
    • Receive News Alerts
    • Glossary
    • RSS
    • Price Check Calculator
    • Annual Reports